{"url_path":"/sec/aixn/10-k/2026/cover-page","section_key":"cover-page","section_title":"Cover Page","topic":"sec","document":{"doc_type":"10-K","doc_date":"2026-05-15","source_url":"https://www.sec.gov/Archives/edgar/data/835662/0001493152-26-023606-index.html","accession_number":"0001493152-26-023606","cik":"0000835662","ticker":"AIXN","issuer_name":"AiXin Life International, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/835662/0001493152-26-023606-index.html","primary_entity_key":"0000835662","primary_entity_name":"AiXin Life International, Inc."},"word_count":1362,"has_tables":true,"body_markdown":"false\nFY\n0000835662\n\n0000835662\n\n2025-01-01\n2025-12-31\n\n0000835662\n\n2025-06-30\n\n0000835662\n\n2026-05-12\n\n0000835662\n\n2025-12-31\n\n0000835662\n\n2024-12-31\n\n0000835662\n\nus-gaap:NonrelatedPartyMember\n\n2025-12-31\n\n0000835662\n\nus-gaap:NonrelatedPartyMember\n\n2024-12-31\n\n0000835662\n\nus-gaap:RelatedPartyMember\n\n2025-12-31\n\n0000835662\n\nus-gaap:RelatedPartyMember\n\n2024-12-31\n\n0000835662\n\n2024-01-01\n2024-12-31\n\n0000835662\n\nAIXN:DirectSalesMember\n\n2025-01-01\n2025-12-31\n\n0000835662\n\nAIXN:DirectSalesMember\n\n2024-01-01\n2024-12-31\n\n0000835662\n\nAIXN:PharmaciesMember\n\n2025-01-01\n2025-12-31\n\n0000835662\n\nAIXN:PharmaciesMember\n\n2024-01-01\n2024-12-31\n\n0000835662\n\nsrt:HotelMember\n\n2025-01-01\n2025-12-31\n\n0000835662\n\nsrt:HotelMember\n\n2024-01-01\n2024-12-31\n\n0000835662\n\nAIXN:ManufactureAndSaleMember\n\n2025-01-01\n2025-12-31\n\n0000835662\n\nAIXN:ManufactureAndSaleMember\n\n2024-01-01\n2024-12-31\n\n0000835662\n\nus-gaap:CommonStockMember\n\n2023-12-31\n\n0000835662\n\nus-gaap:AdditionalPaidInCapitalMember\n\n2023-12-31\n\n0000835662\n\nAIXN:StatutoryReservesMember\n\n2023-12-31\n\n0000835662\n\nus-gaap:RetainedEarningsMember\n\n2023-12-31\n\n0000835662\n\nus-gaap:AccumulatedOtherComprehensiveIncomeMember\n\n2023-12-31\n\n0000835662\n\n2023-12-31\n\n0000835662\n\nus-gaap:CommonStockMember\n\n2024-12-31\n\n0000835662\n\nus-gaap:AdditionalPaidInCapitalMember\n\n2024-12-31\n\n0000835662\n\nAIXN:StatutoryReservesMember\n\n2024-12-31\n\n0000835662\n\nus-gaap:RetainedEarningsMember\n\n2024-12-31\n\n0000835662\n\nus-gaap:AccumulatedOtherComprehensiveIncomeMember\n\n2024-12-31\n\n0000835662\n\nus-gaap:CommonStockMember\n\n2024-01-01\n2024-12-31\n\n0000835662\n\nus-gaap:AdditionalPaidInCapitalMember\n\n2024-01-01\n2024-12-31\n\n0000835662\n\nAIXN:StatutoryReservesMember\n\n2024-01-01\n2024-12-31\n\n0000835662\n\nus-gaap:RetainedEarningsMember\n\n2024-01-01\n2024-12-31\n\n0000835662\n\nus-gaap:AccumulatedOtherComprehensiveIncomeMember\n\n2024-01-01\n2024-12-31\n\n0000835662\n\nus-gaap:CommonStockMember\n\n2025-01-01\n2025-12-31\n\n0000835662\n\nus-gaap:AdditionalPaidInCapitalMember\n\n2025-01-01\n2025-12-31\n\n0000835662\n\nAIXN:StatutoryReservesMember\n\n2025-01-01\n2025-12-31\n\n0000835662\n\nus-gaap:RetainedEarningsMember\n\n2025-01-01\n2025-12-31\n\n0000835662\n\nus-gaap:AccumulatedOtherComprehensiveIncomeMember\n\n2025-01-01\n2025-12-31\n\n0000835662\n\nus-gaap:CommonStockMember\n\n2025-12-31\n\n0000835662\n\nus-gaap:AdditionalPaidInCapitalMember\n\n2025-12-31\n\n0000835662\n\nAIXN:StatutoryReservesMember\n\n2025-12-31\n\n0000835662\n\nus-gaap:RetainedEarningsMember\n\n2025-12-31\n\n0000835662\n\nus-gaap:AccumulatedOtherComprehensiveIncomeMember\n\n2025-12-31\n\n0000835662\n\nAIXN:ChinaConcentricCapitalGroupMember\nAIXN:MrQuanzhongLinMember\n\n2017-02-02\n2017-02-02\n\n0000835662\n\nAIXN:MrQuanzhongLinMember\n\n2017-12-12\n2017-12-12\n\n0000835662\n\nAIXN:HotelPurchaseAgreementMember\nAIXN:AixinShangyanHotelManagementCoLtdMember\n\n2021-05-25\n\n0000835662\n\nAIXN:HotelPurchaseAgreementMember\nAIXN:AixinShangyanHotelManagementCoLtdMember\nAIXN:MrQuanzhongLinMember\n\n2021-05-24\n2021-05-25\n\n0000835662\n\nAIXN:HotelPurchaseAgreementMember\nAIXN:AixinShangyanHotelManagementCoLtdMember\n\n2021-05-25\n2021-05-25\n\n0000835662\n\nAIXN:PharmaciesPurchaseAgreementMember\nAIXN:AixintangPharmacisesMember\n\n2021-06-02\n2021-06-02\n\n0000835662\n\nAIXN:EquityTransferAgreementMember\nAIXN:YunnanRuncangshengTechnologyCompanyLtdMember\n\n2022-07-19\n2022-07-19\n\n0000835662\n\nAIXN:YunnanRuncangshengTechnologyCompanyLtdMember\nAIXN:EquityTransferAgreementMember\n\n2022-07-18\n2022-07-19\n\n0000835662\n\n2023-02-17\n2023-02-17\n\n0000835662\n\n2023-02-17\n\n0000835662\n\n2025-01-01\n\n0000835662\n\nus-gaap:ProductMember\n\n2025-01-01\n2025-12-31\n\n0000835662\n\nAIXN:PharmaciesMember\nsrt:MinimumMember\n\n2025-01-01\n2025-12-31\n\n0000835662\n\nAIXN:PharmaciesMember\nsrt:MaximumMember\n\n2025-01-01\n2025-12-31\n\n0000835662\n\nus-gaap:SalesRevenueNetMember\nus-gaap:CustomerConcentrationRiskMember\nAIXN:OneCustomerMember\n\n2025-01-01\n2025-12-31\n\n0000835662\n\nus-gaap:SalesRevenueNetMember\nus-gaap:CustomerConcentrationRiskMember\nAIXN:OneCustomerMember\n\n2024-01-01\n2024-12-31\n\n0000835662\n\nus-gaap:SalesRevenueNetMember\nus-gaap:CustomerConcentrationRiskMember\nAIXN:TwoCustomerMember\n\n2024-01-01\n2024-12-31\n\n0000835662\n\nAIXN:OfficeFurnitureMember\nsrt:MinimumMember\n\n2025-12-31\n\n0000835662\n\nAIXN:OfficeFurnitureMember\nsrt:MaximumMember\n\n2025-12-31\n\n0000835662\n\nAIXN:ElectronicEquipmentMember\nsrt:MinimumMember\n\n2025-12-31\n\n0000835662\n\nAIXN:ElectronicEquipmentMember\nsrt:MaximumMember\n\n2025-12-31\n\n0000835662\n\nus-gaap:MachineryAndEquipmentMember\nsrt:MinimumMember\n\n2025-12-31\n\n0000835662\n\nus-gaap:MachineryAndEquipmentMember\nsrt:MaximumMember\n\n2025-12-31\n\n0000835662\n\nus-gaap:LeaseholdImprovementsMember\nsrt:MinimumMember\n\n2025-12-31\n\n0000835662\n\nus-gaap:LeaseholdImprovementsMember\nsrt:MaximumMember\n\n2025-12-31\n\n0000835662\n\nus-gaap:VehiclesMember\n\n2025-12-31\n\n0000835662\n\nus-gaap:ProductMember\n\n2024-01-01\n2024-12-31\n\n0000835662\n\nAIXN:CostOfSaleMember\nus-gaap:SupplierConcentrationRiskMember\nAIXN:SupplierAMember\n\n2025-01-01\n2025-12-31\n\n0000835662\n\nAIXN:CostOfSaleMember\nus-gaap:SupplierConcentrationRiskMember\nAIXN:SupplierDMember\n\n2025-01-01\n2025-12-31\n\n0000835662\n\nAIXN:CostOfSaleMember\nus-gaap:SupplierConcentrationRiskMember\nAIXN:SupplierAMember\n\n2024-01-01\n2024-12-31\n\n0000835662\n\nAIXN:CostOfSaleMember\nus-gaap:SupplierConcentrationRiskMember\nAIXN:SupplierBMember\n\n2024-01-01\n2024-12-31\n\n0000835662\n\nAIXN:CostOfSaleMember\nus-gaap:SupplierConcentrationRiskMember\nAIXN:SupplierCMember\n\n2024-01-01\n2024-12-31\n\n0000835662\n\nsrt:ChiefExecutiveOfficerMember\nAIXN:SupplierCMember\n\n2025-12-31\n\n0000835662\n\nAIXN:PeriodEndRMBUSExchangeRateMember\n\n2025-12-31\n\n0000835662\n\nAIXN:PeriodEndRMBUSExchangeRateMember\n\n2024-12-31\n\n0000835662\n\nAIXN:PeriodAverageRMBUSExchangeRateMember\n\n2025-12-31\n\n0000835662\n\nAIXN:PeriodAverageRMBUSExchangeRateMember\n\n2024-12-31\n\n0000835662\n\nus-gaap:OperatingSegmentsMember\nus-gaap:ProductMember\n\n2025-01-01\n2025-12-31\n\n0000835662\n\nus-gaap:OperatingSegmentsMember\nus-gaap:ProductMember\n\n2024-01-01\n2024-12-31\n\n0000835662\n\nus-gaap:OperatingSegmentsMember\nAIXN:PharmaciesMember\n\n2025-01-01\n2025-12-31\n\n0000835662\n\nus-gaap:OperatingSegmentsMember\nAIXN:PharmaciesMember\n\n2024-01-01\n2024-12-31\n\n0000835662\n\nus-gaap:OperatingSegmentsMember\nsrt:HotelMember\n\n2025-01-01\n2025-12-31\n\n0000835662\n\nus-gaap:OperatingSegmentsMember\nsrt:HotelMember\n\n2024-01-01\n2024-12-31\n\n0000835662\n\nus-gaap:OperatingSegmentsMember\nAIXN:ManufactureAndSaleMember\n\n2025-01-01\n2025-12-31\n\n0000835662\n\nus-gaap:OperatingSegmentsMember\nAIXN:ManufactureAndSaleMember\n\n2024-01-01\n2024-12-31\n\n0000835662\n\nus-gaap:OperatingSegmentsMember\n\n2025-01-01\n2025-12-31\n\n0000835662\n\nus-gaap:OperatingSegmentsMember\n\n2024-01-01\n2024-12-31\n\n0000835662\n\nus-gaap:OperatingSegmentsMember\nus-gaap:ProductMember\n\n2025-12-31\n\n0000835662\n\nus-gaap:OperatingSegmentsMember\nus-gaap:ProductMember\n\n2024-12-31\n\n0000835662\n\nus-gaap:OperatingSegmentsMember\nAIXN:PharmaciesMember\n\n2025-12-31\n\n0000835662\n\nus-gaap:OperatingSegmentsMember\nAIXN:PharmaciesMember\n\n2024-12-31\n\n0000835662\n\nus-gaap:OperatingSegmentsMember\nsrt:HotelMember\n\n2025-12-31\n\n0000835662\n\nus-gaap:OperatingSegmentsMember\nsrt:HotelMember\n\n2024-12-31\n\n0000835662\n\nus-gaap:OperatingSegmentsMember\nAIXN:ManufactureAndSaleMember\n\n2025-12-31\n\n0000835662\n\nus-gaap:OperatingSegmentsMember\nAIXN:ManufactureAndSaleMember\n\n2024-12-31\n\n0000835662\n\nus-gaap:OperatingSegmentsMember\n\n2025-12-31\n\n0000835662\n\nus-gaap:OperatingSegmentsMember\n\n2024-12-31\n\n0000835662\n\nus-gaap:VehiclesMember\n\n2024-12-31\n\n0000835662\n\nus-gaap:OfficeEquipmentMember\n\n2025-12-31\n\n0000835662\n\nus-gaap:OfficeEquipmentMember\n\n2024-12-31\n\n0000835662\n\nus-gaap:MachineryAndEquipmentMember\n\n2025-12-31\n\n0000835662\n\nus-gaap:MachineryAndEquipmentMember\n\n2024-12-31\n\n0000835662\n\nus-gaap:LeaseholdImprovementsMember\n\n2025-12-31\n\n0000835662\n\nus-gaap:LeaseholdImprovementsMember\n\n2024-12-31\n\n0000835662\n\n2021-12-01\n2021-12-01\n\n0000835662\n\n2021-12-01\n\n0000835662\n\n2025-11-07\n\n0000835662\n\n2025-11-07\n2025-11-07\n\n0000835662\n\nAIXN:AiXinZhonghongBiologicalTechnologyCoLtdMember\n\n2025-12-31\n\n0000835662\n\nAIXN:AixinShangyanHotelManagementMember\nsrt:MaximumMember\n\n2025-12-31\n\n0000835662\n\nAIXN:AixintangPharmacisesMember\nsrt:MinimumMember\n\n2025-12-31\n\n0000835662\n\nAIXN:AixintangPharmacisesMember\nsrt:MaximumMember\n\n2025-12-31\n\n0000835662\n\n2025-11-26\n2025-11-26\n\n0000835662\n\n2025-11-26\n\n0000835662\n\nAIXN:ChengduLishengHuirenPharmacyCoLtdMember\n\n2025-12-31\n\n0000835662\n\nAIXN:ChengduLishengHuirenPharmacyCoLtdMember\n\n2024-12-31\n\n0000835662\n\nAIXN:ChengduCiguFoshouPharmacyCoLtdMember\n\n2025-12-31\n\n0000835662\n\nAIXN:ChengduCiguFoshouPharmacyCoLtdMember\n\n2024-12-31\n\n0000835662\n\nAIXN:SichuanAixintangXinfuPharmacyChainCoLtdMember\n\n2025-12-31\n\n0000835662\n\nAIXN:SichuanAixintangXinfuPharmacyChainCoLtdMember\n\n2024-12-31\n\n0000835662\n\nAIXN:SichuanYunxiTangPharmacyCoLtdMember\n\n2025-12-31\n\n0000835662\n\nAIXN:SichuanYunxiTangPharmacyCoLtdMember\n\n2024-12-31\n\n0000835662\n\nAIXN:ShengcaofengHealthIndustryYunnanCoLtdMember\n\n2025-12-31\n\n0000835662\n\nAIXN:ShengcaofengHealthIndustryYunnanCoLtdMember\n\n2024-12-31\n\n0000835662\n\nAIXN:ChengduAixinInternationalTravelServiceCoLtdMember\n\n2025-12-31\n\n0000835662\n\nAIXN:ChengduAixinInternationalTravelServiceCoLtdMember\n\n2024-12-31\n\n0000835662\n\nAIXN:SichuanAixintangXinfuPharmacyChainCoLtdMember\n\n2025-01-01\n2025-12-31\n\n0000835662\n\nAIXN:SichuanAixintangXinfuPharmacyChainCoLtdMember\n\n2024-01-01\n2024-12-31\n\n0000835662\n\nAIXN:ChengduAixinInternationalTravelServiceCoLtdMember\n\n2025-01-01\n2025-12-31\n\n0000835662\n\nAIXN:ChengduAixinInternationalTravelServiceCoLtdMember\n\n2024-01-01\n2024-12-31\n\n0000835662\n\nAIXN:ChengduLishengHuirenPharmacyCoLtdMember\n\n2025-01-01\n2025-12-31\n\n0000835662\n\nAIXN:ChengduLishengHuirenPharmacyCoLtdMember\n\n2024-01-01\n2024-12-31\n\n0000835662\n\nAIXN:ShengcaofengHealthIndustryYunnanCoLtdMember\n\n2025-01-01\n2025-12-31\n\n0000835662\n\nAIXN:ShengcaofengHealthIndustryYunnanCoLtdMember\n\n2024-01-01\n2024-12-31\n\n0000835662\n\nAIXN:YuefuRestaurantMember\n\n2025-01-01\n2025-12-31\n\n0000835662\n\nAIXN:YuefuRestaurantMember\n\n2024-01-01\n2024-12-31\n\n0000835662\n\nAIXN:SichuanYunxiTangPharmacyCoLtdMember\n\n2025-01-01\n2025-12-31\n\n0000835662\n\nAIXN:SichuanYunxiTangPharmacyCoLtdMember\n\n2024-01-01\n2024-12-31\n\n0000835662\n\nAIXN:ChengduHeshengyuanPharmacyCoLtdMember\n\n2025-01-01\n2025-12-31\n\n0000835662\n\nAIXN:ChengduHeshengyuanPharmacyCoLtdMember\n\n2024-01-01\n2024-12-31\n\n0000835662\n\nAIXN:ChengduCiguFoshouPharmacyCoLtdMember\n\n2025-01-01\n2025-12-31\n\n0000835662\n\nAIXN:ChengduCiguFoshouPharmacyCoLtdMember\n\n2024-01-01\n2024-12-31\n\n0000835662\n\nAIXN:YunnanShengcaofengBiotechnologyCoLtdMember\n\n2025-01-01\n2025-12-31\n\n0000835662\n\nAIXN:YunnanShengcaofengBiotechnologyCoLtdMember\n\n2024-01-01\n2024-12-31\n\n0000835662\n\nAIXN:ShengcaofengHealthIndustryCoLtdMember\n\n2025-12-31\n\n0000835662\n\nAIXN:ShengcaofengHealthIndustryCoLtdMember\n\n2024-12-31\n\n0000835662\n\nAIXN:ChengduHeshengyuanPharmacyCoLtdMember\n\n2025-12-31\n\n0000835662\n\nAIXN:ChengduHeshengyuanPharmacyCoLtdMember\n\n2024-12-31\n\n0000835662\n\nAIXN:ChengduHenhengyuanPharmacyCoLtdMember\n\n2025-12-31\n\n0000835662\n\nAIXN:ChengduHenhengyuanPharmacyCoLtdMember\n\n2024-12-31\n\n0000835662\n\nus-gaap:RelatedPartyMember\nsrt:DirectorMember\n\n2025-12-31\n\n0000835662\n\nus-gaap:RelatedPartyMember\nsrt:DirectorMember\n\n2024-12-31\n\n0000835662\n\nus-gaap:RelatedPartyMember\nsrt:ChiefExecutiveOfficerMember\n\n2025-12-31\n\n0000835662\n\nus-gaap:RelatedPartyMember\nsrt:ChiefExecutiveOfficerMember\n\n2024-12-31\n\n0000835662\n\nAIXN:ChengduWenjiangAixinNanjiangPharmacyCoLtdMember\n\n2025-12-31\n\n0000835662\n\nAIXN:ChengduWenjiangAixinNanjiangPharmacyCoLtdMember\n\n2024-12-31\n\n0000835662\n\nAIXN:ChengduFuxiangTangPharmacyCoLtdMember\n\n2025-12-31\n\n0000835662\n\nAIXN:ChengduFuxiangTangPharmacyCoLtdMember\n\n2024-12-31\n\n0000835662\n\nAIXN:ChengduWenjiangDistrictHenengHupuPharmacyCoLtdMember\n\n2025-12-31\n\n0000835662\n\nAIXN:ChengduWenjiangDistrictHenengHupuPharmacyCoLtdMember\n\n2024-12-31\n\n0000835662\n\nAIXN:SichuanAixinInvestmentCoLtdMember\n\n2025-12-31\n\n0000835662\n\nAIXN:SichuanAixinInvestmentCoLtdMember\n\n2024-12-31\n\n0000835662\n\nAIXN:MianyangAixinCunshanPharmacyMember\n\n2025-12-31\n\n0000835662\n\nAIXN:MianyangAixinCunshanPharmacyMember\n\n2024-12-31\n\n0000835662\n\nAIXN:XiaoyanZhouMember\n\n2025-12-31\n\n0000835662\n\nAIXN:XiaoyanZhouMember\n\n2024-12-31\n\n0000835662\n\nAIXN:HuiliangJiaoMember\n\n2025-12-31\n\n0000835662\n\nAIXN:HuiliangJiaoMember\n\n2024-12-31\n\n0000835662\n\nAIXN:MrQuanzhongLinMember\n\n2025-12-31\n\n0000835662\n\nAIXN:MrQuanzhongLinMember\n\n2024-12-31\n\n0000835662\n\nAIXN:MianyangAixinCunshanPharmacyCoLtdMember\n\n2025-12-31\n\n0000835662\n\nAIXN:MianyangAixinCunshanPharmacyCoLtdMember\n\n2024-12-31\n\n0000835662\n\nAIXN:RuncangshengHealthIndustryYunnanCoLtdMember\n\n2025-12-31\n\n0000835662\n\nAIXN:RuncangshengHealthIndustryYunnanCoLtdMember\n\n2024-12-31\n\n0000835662\n\nus-gaap:ForeignCountryMember\n\n2025-01-01\n2025-12-31\n\n0000835662\n\nus-gaap:ForeignCountryMember\nAIXN:AixinShangyanHotelAndAixintangPharmaciesMember\n\n2025-12-31\n\n0000835662\n\nus-gaap:ForeignCountryMember\nAIXN:AixinShangyanHotelAndAixintangPharmaciesMember\n\n2025-01-01\n2025-12-31\n\n0000835662\n\nAIXN:EmployeesAndContractorsMember\nAIXN:TwoThousandAndNineteenEquityIncentivePlanMember\n\n2019-10-22\n2019-10-22\n\n0000835662\n\nAIXN:EmployeesAndContractorsMember\nAIXN:TwoThousandAndNineteenEquityIncentivePlanMember\n\n2019-10-22\n\n0000835662\n\nAIXN:EmployeesAndContractorsMember\nAIXN:TwoThousandAndNineteenEquityIncentivePlanMember\n\n2019-10-24\n2019-10-24\n\n0000835662\n\nAIXN:EmployeesAndContractorsMember\nAIXN:TwoThousandAndNineteenEquityIncentivePlanMember\n\n2019-10-24\n\n0000835662\n\nAIXN:TwoThousandAndNineteenEquityIncentivePlanMember\n\n2019-10-24\n2019-10-24\n\n0000835662\n\nAIXN:EmployeesAndContractorsMember\n\n2025-01-01\n2025-12-31\n\n0000835662\n\nsrt:MinimumMember\n\n2025-01-01\n2025-12-31\n\n0000835662\n\nsrt:MaximumMember\n\n2025-01-01\n2025-12-31\n\n0000835662\n\nAIXN:LoanAgreementMember\nus-gaap:SubsequentEventMember\n\n2026-01-01\n\n0000835662\n\nAIXN:LoanAgreementMember\nus-gaap:SubsequentEventMember\n\n2026-01-01\n2026-01-01\n\niso4217:USD\n\nxbrli:shares\n\niso4217:USD\n\nxbrli:shares\n\niso4217:CNY\n\nAIXN:Segment\n\nxbrli:pure\n\n \n\n \n\n \n\n**UNITED\nSTATES**\n\n**SECURITIES\nAND EXCHANGE COMMISSION**\n\n**WASHINGTON,\nD.C. 20549**\n\n \n\n**FORM\n10-K**\n\n \n\n☒\n**ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT**\n\n**OF\n1934**\n\n \n\n**FOR\nTHE FISCAL YEAR ENDED DECEMBER 31, 2025**\n\n \n\n**or**\n\n \n\n☐\n**Transition Report Under Section 13 or 15(d) of the Securities Exchange Act of 1934**\n\n \n\nFor\nthe transition period from ______ to_______\n\n \n\n**FOR\nTHE FISCAL YEAR ENDED DECEMBER 31, 2025**\n\n \n\n**Commission\nFile Number: 000-17284**\n\n \n\n \n\n \n\n**AIXIN\nLIFE INTERNATIONAL, INC.**\n\n(Exact\nname of registrant as specified in its charter)\n\n \n\n**Colorado**\n \n**84-1085935**\n\n(State\nor Other Jurisdiction\n \nIRS\nEmployer\n\nof\nIncorporation)\n \nIdentification\nNumber\n\n \n\n**Hongxing\nInternational Business Building 2, 14th FL****,**\nNo. 69 Qingyun South Ave.,\nJinjiang District\n\n**Chengdu\nCity, Sichuan Province, 610021 China**\n\n(Address\nof principal executive offices)\n\n \n\n86-313-6732526\n\n(Registrant’s\ntelephone number, including area code)\n\n \n\nSecurities\nregistered pursuant to Section 12(b) of the Act: **None**\n\n \n\nSecurities\nregistered pursuant to Section 12(g) of the Act:\n\n**Common\nStock, $0.00001 par value**\n\n(Title\nof class)\n\n \n\nIndicate\nby check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☐ No ☒\n\n \n\nIndicate\nby check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ☐ No ☒\n\n \n\nIndicate\nby check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange\nAct of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)\nhas been subject to such filing requirements for the past 90 days. Yes ☒ No ☐\n\n \n\nIndicate\nby check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data\nFile required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding\n12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☐ No ☒\n\n \n\nIndicate\nby check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting\ncompany. (Check one):\n\n \n\nLarge\naccelerated filer ☐\n \nAccelerated\nfiler ☐\n\n \n \n \n\nNon-accelerated\nfiler ☒\n \nSmaller\nreporting company ☒\n\n \n \n \n\n \n \nEmerging\ngrowth company ☐\n\n \n\nIf\nan emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying\nwith any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐\n\n \n\nIndicate\nby check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness\nof its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered\npublic accounting firm that prepared or issued its audit report. ☐\n\n \n\nIf\nsecurities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant\nincluded in the filing reflect the correction of an error to previously issued financial statements. ☐\n\n \n\nIndicate\nby check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation\nreceived by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b). ☐\n\n \n\nIndicate\nby check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ☐ No ☒\n\n \n\nAs\nof June 30, 2025, the aggregate market value of our common stock held by non-affiliates was $883,722 based on 8,579,822 shares of outstanding\ncommon stock held by non-affiliates, and a price of $0.1030 per share, which was the last reported sale price of our common stock on\nOTCQB on that date.\n\n \n\nAs\nof May 12, 2026, we had outstanding 24,999,834 shares of common stock.\n\n \n\nDOCUMENTS\nINCORPORATED BY REFERENCE: None\n\n \n\n \n\n \n\n \n\n \n\n \n\n**AIXIN\nLIFE INTERNATIONAL, INC.**\n\n \n\n \n \n**Page\nNo.**\n\n**PART I**"}